Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals

Luigi Lorenzini(Amsterdam Neuroscience), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Philip Scheltens(Amsterdam University Medical Centers), Sven van der van der Lee(Amsterdam Neuroscience), Pieter Jelle Visser(Karolinska Institutet), Daniel L. McCartney(Edinburgh Cancer Research), Henk Mutsaerts(Amsterdam Neuroscience), Michael Ewers(German Center for Neurodegenerative Diseases), Carole H. Sudre(King's College London), Pierre Payoux(Université Toulouse III - Paul Sabatier), Henne Holstege(Amsterdam University Medical Centers), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Silvia Ingala(Amsterdam Neuroscience), Marcel Reinders(Leiden University), Adam Waldman(Royal Society of Edinburgh), Riccardo E. Marioni(Edinburgh Cancer Research), Juan Domingo Gispert(Lund University), André Altmann(Hawassa University), Alle Meije Wink(University of Cambridge), Sven Haller(Uppsala University), John O’ Brien(University of Cambridge), Natàlia Vilor‐Tejedor(Radboud University Nijmegen), Adam J. Schwarz(Eli Lilly (United States)), Christopher Foley(Baylor College of Medicine), Gael Chatelat(Inserm), Niccoló Tesi(Amsterdam UMC Location University of Amsterdam), Robin Wolz(Ixico (United Kingdom)), Giovanni B. Frisoni(University of Geneva), Betty M. Tijms(Amsterdam Neuroscience), Tiago Gil Oliveira(Hospital Braga), Lyduine E. Collij(Lund University), Kaj Blennow(Sahlgrenska University Hospital)
Alzheimer s & Dementia
July 29, 2024
Cited by 13


Related Papers